Better Prognosis After Complete Revascularization Using Contemporary Coronary Stents in Patients With Chronic Kidney

Doyeon Hwang1, Jeehoon Kang1, Han-Mo Yang1

  • 1Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Republic of Korea.

Insights

Complete revascularization with drug-eluting stents improves outcomes for patients with chronic kidney disease (CKD). A lower residual SYNTAX score target is beneficial for CKD patients, suggesting more aggressive treatment.

Area of Science:

  • Cardiology
  • Nephrology
  • Interventional Cardiology

Background:

  • Prognostic value of complete revascularization in chronic kidney disease (CKD) using contemporary stents is understudied.
  • Second-generation drug-eluting stents are widely used for coronary revascularization.

Purpose of the Study:

  • To compare clinical outcomes of complete versus incomplete revascularization in patients with and without CKD.
  • To evaluate the prognostic impact of angiographic complete revascularization in CKD patients treated with second-generation drug-eluting stents.

Main Methods:

  • Retrospective analysis of 8471 patients from the Grand Drug-Eluting Stent Registry.
  • Patients were stratified into CKD (n=3014) and preserved renal function (n=5457) groups.
  • Complete revascularization defined as a residual SYNTAX score of 0; primary outcome was a 3-year patient-oriented composite outcome.

Main Results:

  • Complete revascularization significantly reduced patient-oriented composite outcomes in both CKD (14.6% vs 21.8%) and preserved renal function groups (8.0% vs 12.0%).
  • Adjusted hazard ratios favored complete revascularization in both groups (CKD: 0.79; preserved function: 0.77).
  • Optimal residual SYNTAX score cutoffs for better outcomes were lower in CKD patients (<3) compared to those with preserved renal function (<8).

Conclusions:

  • Angiographic complete revascularization improves clinical outcomes in patients with CKD and preserved renal function.
  • A lower residual SYNTAX score target is recommended for CKD patients, indicating a need for more aggressive revascularization strategies.
  • These findings support tailored revascularization approaches based on renal function status.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
596
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
574
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
359
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
330
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
909
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
387